Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
Curtiss-Wright Corporation insider transaction: A company officer, serving as Vice President of Strategy and Business Development, reported selling 175 shares of Curtiss-Wright common stock on 11/25/2025 at a price of $546.97 per share. After this sale, the reporting person beneficially owns 3,688 shares of Curtiss-Wright common stock.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that the reporting person adopted on August 26, 2025 and that is maintained by the reporting person’s financial advisor. The filing also notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those ownership requirements.
Curtiss-Wright (CW) has a Form 144 notice covering a planned sale of common stock under SEC Rule 144. The filing indicates that 688 shares of Curtiss-Wright common stock may be sold through Merrill, located at 6000 Fairview Rd., Suite 600, Charlotte, NC 28210, on the NYSE around 11/25/2025, with an aggregate market value of $391,472. The filing states that there were 36,847,638 shares of this class outstanding.
The shares to be sold were originally acquired from the company as stock-based compensation. One grant of common stock was acquired on 02/07/2024 as a stock bonus for 400 shares, and another on 03/18/2024 as a stock bonus for 288 shares, with both transactions described as stock bonus payments on their respective dates.
Curtiss-Wright Corporation announced that its Board of Directors has authorized the company to repurchase up to an additional $416 million of its common stock, bringing the total available share repurchase authorization to $550 million, including $134 million remaining from prior programs. The company may repurchase shares through methods such as open market purchases, accelerated share repurchase transactions, negotiated block trades, Rule 10b5-1 plans, and other brokered or privately negotiated transactions.
The company also adopted two Rule 10b5-1 trading plans that begin on January 2, 2026 and end on December 31, 2026. One plan contemplates purchases totaling $60 million executed evenly over calendar year 2026, while a second plan provides for potential purchases up to $100 million, subject to a price limit that could prevent purchases. A designated broker will execute repurchases under these plans, and future periodic reports will provide updates on actual share repurchase activity.
Curtiss-Wright Corporation (CW) Chair and CEO Lynn M. Bamford reported an open market sale of company stock. On 11/14/2025, 3,750 shares of Curtiss-Wright common stock were sold at an average price of $549.07 per share. After this transaction, the reporting person beneficially owns 35,413 shares of Curtiss-Wright common stock in direct form. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025 and is stated to comply with the company’s share ownership guidelines.
Form 144 filing indicates a proposed sale of CW common stock. The notice lists 3,750 shares to be sold through UBS Financial Services, Inc., with an aggregate market value of $2,008,968.00. The approximate sale date is 11/14/2025, and the securities are listed on the NYSE.
The shares to be sold were acquired as RSUs on 02/05/2024 from the issuer, in the amount of 3,750. Shares outstanding are shown as 36,874,638. The recent sales section reports that Lynn Bamford sold 3,750 common shares on 11/11/2025 for gross proceeds of $2,166,705.75.
Curtiss-Wright (CW) insider transaction: Vice President and CFO K. Christopher Farkas reported an open market sale of 5,047 shares of common stock on 11/11/2025 at an average price of $577.91, coded “S.” The sale was executed under a Rule 10b5-1 trading plan adopted on August 11, 2025 and complies with the company’s share ownership guidelines.
Following the sale, the officer directly owns 4,236 shares. The filing notes the shares were sold in multiple trades within a price range of $574.14 to $579.17, and the reporting person will provide full trade details upon request.
Curtiss-Wright (CW) reported an insider transaction by Chair and CEO (and Director) Lynn M. Bamford. On 11/11/2025, the reporting person sold 3,750 shares of common stock at an average price of $577.79, with trades executed between $573.46 and $577.33. Following the sale, the reporting person beneficially owns 39,163 shares directly. The sale was conducted under a Rule 10b5-1 trading plan adopted on August 12, 2025 and in compliance with the company’s share ownership guidelines.
Curtiss-Wright (CW): A selling securityholder filed a Form 144 for Curtiss‑Wright common stock, indicating an intended sale of 3,750 shares on the NYSE, through UBS Financial Services, Inc., with an aggregate market value of $2,166,705.75. The filing lists an approximate sale date of 11/12/2025.
The securities to be sold were acquired via RSU grants from the issuer: 3,300 shares on 03/18/2024 and 450 shares on 02/05/2024. Shares outstanding were 36,874,638; this is a baseline figure, not the amount being sold.
CW: A security holder filed a Form 144 notice to sell up to 5,047 shares of common stock, with an aggregate market value of $2,916,721.36. The filing lists UBS Financial Services Inc. as broker and identifies the NYSE as the exchange, with an approximate sale date of 11/12/2025.
The shares to be sold were acquired through restricted stock units (RSUs) and performance share vesting across multiple dates from 2019 to 2023. Shares outstanding were reported as 36,874,638; this is a baseline figure, not the amount being offered.
Curtiss-Wright Corporation reported solid third-quarter performance. Net sales reached $869.2 million (up 9% year over year), led by growth in Naval & Power and steady gains in Defense Electronics and Aerospace & Industrial. Operating income rose to $166.3 million, with operating margin improving to 19.1%. Diluted EPS was $3.31, up from $2.89.
Segment results were broad-based: Defense Electronics posted a 29.2% operating margin on higher embedded computing sales; Naval & Power sales increased 12% on submarine programs and commercial nuclear activity; Aerospace & Industrial grew 8% on demand for actuation, sensors, and surface treatment.
Year to date, operating cash flow was $290.7 million. The company repurchased $325.1 million of stock (about 684,000 shares) and raised the quarterly dividend to $0.24 per share. Backlog was approximately $3.9 billion, with about 90% expected to convert to revenue over the next 36 months. Shares outstanding were 36,874,638 as of October 31, 2025.